About BioExsen

BioeXsen develops products for rapid pathogen diagnosis with molecular biotechnology tools in the area of human health with the production and distribution of immunobiological and isopathic medicinal products in human biology.

The preparations obtained in high-purity laboratories from bacterial and mold cultures are manufactured in a complex process under GMP conditions and are subject to the strictest quality and safety controls. The production is still carried out today according to the process developed in human biology, in which the smallest specific protein fractions are obtained from the bacterial and mold cultures, which develop their special potential in the organism.

BioeXsen, which operates ISO 9001 and 13485 quality management systems, increases its production capacity day by day and provides diagnostic kits to the whole world.

​

We combine years of experience with the latest scientific findings in our preparations.

​

BioeXsen we also provide technical support in all matters relating to the setting,establishment and operation of an innovative solution for combatting the pandemic. Our group is an official test partner of the free and hanseatic city of Hamburg, German Health Ministry and institutions trust in our services the authority for justice and consumer protection, Hamburg port authority and many more.

PARTNERS

ENDEKS HOLDING

With over 25 years of experience Endeks Holding and Group Companies focus on different strategic investments. Diversification and innovation is the key for our success.

BIOEKSEN

Bioeksen R&D Technologies is a Turkish company established in 2014, which develops molecular products for rapid pathogen diagnosis in the areas of human health, animal health and food safety

Overview